SinocellTech Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
2,300
- Stock Symbol
-
688520
- Share Price
-
$4.45
- (As of Friday Closing)
SinocellTech General Information
Description
Sinocelltech Group Ltd is one of Chin's biopharma companies specializing in biologics and vaccines. The company's therapeutic areas include oncology, immunology and inflammation, ophthalmology, and prophylactic vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. The capabilities of the company include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up, protein purification development, and large scale production.
Contact Information
Website
www.sinocelltech.comCorporate Office
- Number 31, Kechuang 7th Street
- Beijing Economic-Technological Development Area
- Beijing, 100176
- China
Corporate Office
- Number 31, Kechuang 7th Street
- Beijing Economic-Technological Development Area
- Beijing, 100176
- China
SinocellTech Stock Performance
As of 13-Nov-2026, SinocellTech’s stock price is $4.45. Its current market cap is $2.09B with 470M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.45 | $4.64 | $4.33 - $7.38 | $2.09B | 470M | 2.55M | -$0.31 |
SinocellTech Financials Summary
As of 30-Sep-2026, SinocellTech has a trailing 12-month revenue of $165M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,977,962 | 3,240,326 | 2,567,924 | 3,698,552 |
| Revenue | 165,404 | 216,949 | 350,181 | 266,768 |
| EBITDA | (131,189) | (42,004) | 51,422 | (25,086) |
| Net Income | (138,980) | (78,546) | 15,602 | (55,975) |
| Total Assets | 549,274 | 546,584 | 449,856 | 383,508 |
| Total Debt | 424,390 | 447,840 | 348,262 | 387,389 |
SinocellTech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SinocellTech Comparisons
Industry
Financing
Details
SinocellTech Competitors (18)
One of SinocellTech’s 18 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| BioAtla | Formerly VC-backed | San Diego, CA | ||||
| BeOne Medicines | Formerly PE-Backed | Beijing, China |
SinocellTech Signals
SinocellTech ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
37.46 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
SinocellTech FAQs
-
When was SinocellTech founded?
SinocellTech was founded in 2002.
-
Where is SinocellTech headquartered?
SinocellTech is headquartered in Beijing, China.
-
What is the size of SinocellTech?
SinocellTech has 2,300 total employees.
-
What industry is SinocellTech in?
SinocellTech’s primary industry is Drug Discovery.
-
Is SinocellTech a private or public company?
SinocellTech is a Public company.
-
What is SinocellTech’s stock symbol?
The ticker symbol for SinocellTech is 688520.
-
What is the current stock price of SinocellTech?
As of 13-Nov-2026 the stock price of SinocellTech is $4.45.
-
What is the current market cap of SinocellTech?
The current market capitalization of SinocellTech is $2.09B.
-
What is SinocellTech’s current revenue?
The trailing twelve month revenue for SinocellTech is $165M.
-
Who are SinocellTech’s competitors?
CytomX Therapeutics, Adaptimmune Therapeutics, Carisma Therapeutics, BioAtla, and BeOne Medicines are some of the 18 competitors of SinocellTech.
-
What is SinocellTech’s annual earnings per share (EPS)?
SinocellTech’s EPS for 12 months was -$0.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process